A Bimodal Association of Vitamin D Levels and Vascular Disease in Children on Dialysis
- 1 June 2008
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (6) , 1239-1246
- https://doi.org/10.1681/asn.2007090993
Abstract
Trol subjects. All dialysis patients were prescribed daily oral 1-α hydroxyvitamin D3. 92% of patients were deficient in 25-hydroxyvitamin D [25(OH)D]. 1,25-dihydroxyvitamin D [1,25(OH)2D] levels were low in 36% and high in 11% of patients. There was a weak correlation between 1α-hydroxyvitamin D3 dosage and 1,25(OH)2D levels. Both carotid intima-media thickness and calcification scores showed a U-shaped distribution across 1,25(OH)2D levels: patients with both low and high 1,25(OH)2D had significantly greater carotid intima-media thickness (P < 0.0001) and calcification (P = 0.0002) than those with normal levels. Low 1,25(OH)2D levels were associated with higher high-sensitivity C-reactive protein (P < 0.0001). Calcification was most frequently observed in patients with the lowest 1,25(OH)2D and the highest high-sensitivity C-reactive protein. In contrast, 25(OH)D levels did not correlate with any vascular measure. In conclusion, both low and high 1,25(OH)2D levels are associated with adverse morphologic changes in large arteries, and this may be mediated through the effects of 1,25(OH)2D on calcium-phosphate homeostasis and inflammation. For optimization of strategies to protect the vasculature of dialysis patients, careful monitoring of 1,25(OH)2D levels may be required....Keywords
This publication has 44 references indexed in Scilit:
- Mineral Metabolism and Vascular Damage in Children on DialysisJournal of the American Society of Nephrology, 2007
- Calciotropic Hormones and Arterial PhysiologyJournal of the American Society of Nephrology, 2007
- Coronary artery calcifications in children with end-stage renal diseasePediatric Nephrology, 2006
- Vascular calcification: A stiff challenge for the nephrologistKidney International, 2004
- Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidismKidney International, 2003
- 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJournal of Clinical Investigation, 2002
- Calcitriol Therapy Modulates the Cellular Immune Responses in Hemodialysis PatientsAmerican Journal of Nephrology, 2000
- 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional levelCytokine, 1992
- 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth.Hypertension, 1989
- 1,25-dihydroxyvitamin D3 stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived from rat aortaBiochemical and Biophysical Research Communications, 1988